Palatable formulations
US12115162B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Feb 19, 2020 |
| Grant date | Oct 15, 2024 |
| Priority date | — |
| Expiry date | Sep 29, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/46
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to a soft chewable composition comprising or containing a therapeutically effective amount of a veterinary active agent, preferably a JAK inhibitor; an animal based palatant, a non-animal based palatant, a flavor modifier, and at least one veterinary acceptable excipient that is selected from at least one each of a disintegrant, binder, lubricant, humectant, and glidant; and wherein the soft chewable tablet is compressed with a rotary tablet press; and methods for treating or preventing cancer, asthma, atopic dermatitis, autoimmune disorders, pruritus associated with allergic dermatitis, allergies, and chronic respiratory disease in an animal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.